---
title: "Morning Trend | Chugai Pharmaceutical (ADR) rebounds after hitting a low, is a short-term rebound opportunity emerging?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283192794.md"
description: "No text available"
datetime: "2026-04-20T13:00:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283192794.md)
  - [en](https://longbridge.com/en/news/283192794.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283192794.md)
generator: "portal-rs"
---

# Morning Trend | Chugai Pharmaceutical (ADR) rebounds after hitting a low, is a short-term rebound opportunity emerging?

No text available

### Related Stocks

- [CHGCY.US](https://longbridge.com/en/quote/CHGCY.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [4519.JP](https://longbridge.com/en/quote/4519.JP.md)

## Related News & Research

- [Chugai licenses anti-dengue antibody AID351 to GSK in exclusive deal](https://longbridge.com/en/news/296167792.md)
- [Chugai files Japan application for Tecentriq as adjuvant MSI-high colon cancer treatment](https://longbridge.com/en/news/295890880.md)
- [SBIO: U.S. Programmatic and EMEA drove 49% of Q2 sales, with margins rising to 61% and profitability expected in H2 2026](https://longbridge.com/en/news/296517769.md)
- [Rani Therapeutics Expands Oral Biologics Push With Obesity, Immunology Pipeline](https://longbridge.com/en/news/296030806.md)
- [Moderna surges on trial win for cancer shot; William Blair upgrades](https://longbridge.com/en/news/296370751.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**